PATENT CLAIM ANALYSIS

Application Number: 16136334
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "013500"]

Abstract:
The present invention relates to a method of preventing or treating hemorrhagic shock (HS), or ameliorating symptoms associated with HS in an individual, by administering an effective amount of a linear, non-cyclic peptide comprising 17 to 21 amino acids, wherein the amino acids in positions (1) to (21) of the peptide, counted from the N-terminus, are as follows: (1) G, S or lacking; (2) C or lacking; (3) K or R; (4) K or R; (5) Y or F; (6) K or R; (7) K or R; (8) F, W or L; (9) K, R or lacking; (10) W, L or F; (11) K or R; (12) F, Y or C; (13) K or R; (14) G or Q; (15) K or R; (16) F, L or W; (17) F or W; (18) F, L or W; (19) W or F; (20) C or lacking; (21) G or lacking, wherein when position (9) is lacking, positions (1) and (21) cannot be lacking.

Claim (Index 11):
The method according to  claim 10 , wherein the peptide is in D-configuration.

Metadata:
- Claim Count in Document: 54.0
- Percentile: 97.0
- Lexical Diversity: 2.98824
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12936976', '12168513', '12681857', '12432528', '13595250']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7382079789597614
- 35 USC 102 Novelty (BERT): 0.5254003467165177
- Combined Prediction Score: 0.716927215735437
- Mean Citation Score: 263.542484
- Max Citation Score: 305.28293
- Similarity Product: 218.8494325944996

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test